Our financial reporting year now ends in July to align our accounts with those of our parent company, the University of Oxford, in accordance with new financial reporting standards for the UK and Ireland, FRS102. This report covers a 16 month period to accommodate this adjustment from our previous financial year.

All the major metrics of activity grew, making this another record-breaking year. In April we celebrated the milestone of a cumulative total of £100m raised in first round investment for spinouts from Oxford.

Revenues

2015 included exceptional revenue arising from the assignment of IP to Sequenom Inc.

£22.2m

2016 (Apr15 – Jul16)

£24.6m

2015 (Apr14 – Mar15)

Distributions

Returned to Oxford University and its researchers

£9.6m

2016 (Apr15 – Jul16)

£13.6m

2015 (Apr14 – Mar15)

Translational Funding

Awarded to Oxford researchers with OUI assistance

£14m

2016 (Apr15 – Jul16)

£25m

2015 (Apr14 – Mar15)

Innovation Consultancy

Consultancy days delivered

3535

2016 (Apr15 – Jul16)

2686

2015 (Apr14 – Mar15)

Patents

Patents and applications under OUI management

2873

2016 (Apr15 – Jul16)

2490

2015 (Apr14 – Mar15)

Deals

855

2016 (Apr15 – Jul16)

597

2015 (Apr14 – Mar15)

Academic Consultants

Number utilised

418

2016 (Apr15 – Jul16)

305

2015 (Apr14 – Mar15)

Spinouts

21

2016 (Apr15 – Jul16)

5

2015 (Apr14 – Mar15)

Back to Top
Responsive Menu Pro Image Responsive Menu Clicked Image